Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia

Virchows Archiv

Volumn 455, Issue 1, 2009, Pages 43-48

  Koperek, Oskar ^a   Prinz, Astrid ^a   Scheuba, Christian ^a   Niederle, Bruno ^a   Kaserer, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

C cell hyperplasia; Medullary thyroid carcinoma; Tenascin C

Indexed keywords

TENASCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CHILD; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE RET; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; FEMALE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-RET; TENASCIN; THYROID NEOPLASMS;

EID: 67650725513     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0786-y     Document Type: Article

References (39)

1. CJ Lips RM Landsvater JW Hoppener 1994 Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A N Engl J Med 331 828 835 (Pubitemid 24289709)
2. N Barbot C Calmettes I Schuffenecker 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma J Clin Endocrinol Metab 78 114 120
3. F Pacini M Fontanelli L Fugazzola 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma J Clin Endocrinol Metab 78 826 829 (Pubitemid 24118072)
4. H Vierhapper W Raber C Bieglmayer 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases J Clin Endocrinol Metab 82 1589 1593 (Pubitemid 27200439)
5. K Kaserer C Scheuba N Neuhold 1998 C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin Am J Surg Pathol 22 722 728 (Pubitemid 28280274)
6. JE Krueger A Maitra J Albores-Saavedra 2000 Inherited medullary microcarcinoma of the thyroid: a study of 11 cases Am J Surg Pathol 24 853 858 (Pubitemid 30366273)
7. SJ Diaz-Cano M de Miguel A Blanes 2001 Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia J Clin Endocrinol Metab 86 3948 3957 (Pubitemid 32756002)
8. A Machens P Niccoli-Sire J Hoegel 2003 Early malignant progression of hereditary medullary thyroid cancer N Engl J Med 349 1517 1525 (Pubitemid 37255037)
9. A Perry K Molberg J Albores-Saavedra 1996 Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities Cancer 77 750 756 (Pubitemid 26055401)
10. K Kaserer C Scheuba N Neuhold 2001 Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients Am J Surg Pathol 25 1245 1251 (Pubitemid 32917117)
11. E Saggiorato I Rapa F Garino 2007 Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia J Mol Diagn 9 214 219 (Pubitemid 47305088)
12. U Verga S Ferrero L Vicentini 2007 Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr Relat Cancer 14 393 403 (Pubitemid 47242638)
13. S Guyetant N Josselin F Savagner 2003 C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients Mod Pathol 16 756 763 (Pubitemid 37011070)
14. O Koperek C Scheuba M Cherenko 2008 Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential Histopathology 52 623 630
15. O Koperek C Scheuba C Puri 2007 Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma Int J Oncol 31 59 67
16. C Scheuba K Kaserer K Kaczirek 2006 Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases World J Surg 30 853 859 (Pubitemid 43724117)
17. PL Jones 2001 Extracellular matrix and tenascin-C in pathogenesis of breast cancer Lancet 357 1992 1994 (Pubitemid 32592382)
18. S Hauptmann L Zardi A Siri 1995 Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms Lab Invest 73 172 182
19. S Hauptmann D Budianto C Denkert 2003 Adhesion and migration of HRT-18 colorectal carcinoma cells on extracellular matrix components typical for the desmoplastic stroma of colorectal adenocarcinomas Oncology 65 174 181 (Pubitemid 37025980)
20. R Chiquet-Ehrismann RP Tucker 2004 Connective tissues: signalling by tenascins Int J Biochem Cell Biol 36 1085 1089 (Pubitemid 38501560)
21. T Sethi RC Rintoul SM Moore 1999 Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo Nat Med 5 662 668 (Pubitemid 29289430)
22. S Maschler S Grunert A Danielopol 2004 Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells Oncogene 23 3622 3633 (Pubitemid 38658429)
23. JA Tuxhorn GE Ayala MJ Smith 2002 Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling Clin Cancer Res 8 2912 2923 (Pubitemid 35025739)
24. BF Iskaros LG Koss 2000 Tenascin expression in intraepithelial neoplasia and invasive carcinoma of the uterine cervix Arch Pathol Lab Med 124 1282 1286 (Pubitemid 30694077)
25. C Goepel S Stoerer H Koelbl 2003 Tenascin in preinvasive lesions of the vulva and vulvar cancer Anticancer Res 23 4587 4591 (Pubitemid 38173871)
26. AA Howeedy I Virtanen L Laitinen 1990 Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast Lab Invest 63 798 806
27. M Fink A Weinhusel B Niederle 1996 Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)" Int J Cancer 69 312 316
28. C Scheuba K Kaserer A Moritz 2009 Sporadic hypercalcitoninemia: clinical and therapeutic consequences Endocr Relat Cancer 16 1 243 253
29. C Bieglmayer C Scheuba B Niederle 2002 Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin Wien Klin Wochenschr 114 267 273 (Pubitemid 34450419)
30. DeLellis R (2004) Pathology and Genetics of Tumors of the Endocrine Organs. IARC, Lyon
31. EJ Mackie 1994 Tenascin in connective tissue development and pathogenesis Perspect Dev Neurobiol 2 125 132
32. EJ Mackie 1997 Molecules in focus: tenascin-C Int J Biochem Cell Biol 29 1133 1137
33. A Machens HJ Holzhausen PN Thanh 2003 Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations Surgery 134 425 431 (Pubitemid 37215147)
34. A Brunner C Mayerl A Tzankov 2004 Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer J Clin Pathol 57 927 931 (Pubitemid 39208242)
35. A Ishihara T Yoshida H Tamaki 1995 Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance Clin Cancer Res 1 1035 1041
36. RP Tucker SE McKay 1991 The expression of tenascin by neural crest cells and glia Development 112 1031 1039 (Pubitemid 21900304)
37. L Martinez MD Ceano-Vivas S Gonzalez-Reyes 2005 Decrease of parafollicular thyroid C-cells in experimental esophageal atresia: further evidence of a neural crest pathogenic pathway Pediatr Surg Int 21 175 179 (Pubitemid 40468876)
38. AF Russo MS Clark PL Durham 1996 Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons Mol Neurobiol 13 257 276 (Pubitemid 126715879)
39. Y Kameda 1995 Evidence to support the distal vagal ganglion as the origin of C cells of the ultimobranchial gland in the chick J Comp Neurol 359 1 14